Found: 11
Select item for more details and to access through your institution.
Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation.
- Published in:
- Science Signaling, 2024, v. 17, n. 824, p. 1, doi. 10.1126/scisignal.adg9256
- By:
- Publication type:
- Article
Therapeutic activation of endothelial sphingosine‐1‐phosphate receptor 1 by chaperone‐bound S1P suppresses proliferative retinal neovascularization.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 5, p. 1, doi. 10.15252/emmm.202216645
- By:
- Publication type:
- Article
Sphingosine 1‐Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex–Induced Vascular Injury.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 11, p. 1879, doi. 10.1002/art.40558
- By:
- Publication type:
- Article
An engineered S1P chaperone attenuates hypertension and ischemic injury.
- Published in:
- Science Signaling, 2017, v. 10, n. 492, p. 1, doi. 10.1126/scisignal.aal2722
- By:
- Publication type:
- Article
Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays.
- Published in:
- Biochemical Journal, 2017, v. 474, n. 9, p. 1467, doi. 10.1042/BCJ20170075
- By:
- Publication type:
- Article
Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.
- Published in:
- FASEB Journal, 2016, v. 30, n. 6, p. 2351, doi. 10.1096/fj.201500064
- By:
- Publication type:
- Article
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P<sub>1</sub> to limit vascular inflammation.
- Published in:
- Science Signaling, 2015, v. 8, n. 389, p. 1, doi. 10.1126/scisignal.aaa2581
- By:
- Publication type:
- Article
HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.
- Published in:
- Nature, 2015, v. 523, n. 7560, p. 342, doi. 10.1038/nature14462
- By:
- Publication type:
- Article
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 2, p. 928, doi. 10.1172/JCI66168
- By:
- Publication type:
- Article
ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
- Published in:
- Journal of Molecular Medicine, 2010, v. 88, n. 5, p. 497, doi. 10.1007/s00109-010-0591-8
- By:
- Publication type:
- Article
ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.
- Published in:
- Nature Immunology, 2006, v. 7, n. 12, p. 1293, doi. 10.1038/ni1399
- By:
- Publication type:
- Article